» Articles » PMID: 30443291

Immortalized Murine Fibroblast Cell Lines Are Refractory to Reprogramming to Pluripotent State

Overview
Journal Oncotarget
Specialty Oncology
Date 2018 Nov 17
PMID 30443291
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

To date different cell types of various mammalian species have been reprogrammed to induced pluripotent stem cells (iPSCs) using Yamanaka's cocktail of transcription factors (Oct4, Klf4, Sox2, and cMyc). It has been shown that several primary human cancer cell lines could be reprogrammed to iPSCs. We sought if immortalized mouse fibroblast cell lines could also be reprogrammed to iPSCs. The approach of generating iPSCs from such cells should be valuable in different experimental settings as it allows clonally derive cell lines carrying mutations whose impact on reprogramming could be next evaluated. Therefore, we investigated reprogramming of widely used immortalized cell lines (NIH3T and STO), as well as of immortalized fibroblast line (tKM) with the use of highly effective lentiviral polycistronic OKSM expression system. Our reprogramming experiments have shown that in contrast to mouse embryonic fibroblasts (MEFs), none of the immortalized cell lines can be reprogrammed to pluripotent state. Contrary to colonies derived from MEFs, those derived from the immortalized cells lines (1) developed much later, (2) contained large round cells, not typical for iPSCs, and (3) were negative for trusted markers of matured iPSCs, Nanog and SSEA1. Immortalized cell lines NIH3T and STO are known to be mostly aneuploid, whereas tKM population includes cells with normal karyotype, however, neither cell type can be reprogrammed. Thus our data argue that aneuploidy is not a reason for the observed refractoriness of mouse immortalized cells to reprogramming to pluripotent state.

Citing Articles

Transcriptome-Wide Insights: Neonatal Lactose Intolerance Promotes Telomere Damage, Senescence, and Cardiomyopathy in Adult Rat Heart.

Anatskaya O, Ponomartsev S, Elmuratov A, Vinogradov A Int J Mol Sci. 2025; 26(4).

PMID: 40004050 PMC: 11855832. DOI: 10.3390/ijms26041584.


Polyploidy Promotes Hypertranscription, Apoptosis Resistance, and Ciliogenesis in Cancer Cells and Mesenchymal Stem Cells of Various Origins: Comparative Transcriptome In Silico Study.

Anatskaya O, Vinogradov A Int J Mol Sci. 2024; 25(8).

PMID: 38673782 PMC: 11050069. DOI: 10.3390/ijms25084185.


Differentiation shifts from a reversible to an irreversible heterochromatin state at the DM1 locus.

Handal T, Juster S, Abu Diab M, Yanovsky-Dagan S, Zahdeh F, Aviel U Nat Commun. 2024; 15(1):3270.

PMID: 38627364 PMC: 11021500. DOI: 10.1038/s41467-024-47217-4.


Metabolic control of induced pluripotency.

Sinenko S, Tomilin A Front Cell Dev Biol. 2024; 11:1328522.

PMID: 38274274 PMC: 10808704. DOI: 10.3389/fcell.2023.1328522.


Evaluation of the determinants for improved pluripotency induction and maintenance by engineered SOX17.

Hu H, Ho D, Tan D, MacCarthy C, Yu C, Weng M Nucleic Acids Res. 2023; 51(17):8934-8956.

PMID: 37607832 PMC: 10516664. DOI: 10.1093/nar/gkad597.


References
1.
Hong H, Takahashi K, Ichisaka T, Aoi T, Kanagawa O, Nakagawa M . Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature. 2009; 460(7259):1132-5. PMC: 2917235. DOI: 10.1038/nature08235. View

2.
Makarev E, Fortney K, Litovchenko M, Braunewell K, Zhavoronkov A, Atala A . Quantifying signaling pathway activation to monitor the quality of induced pluripotent stem cells. Oncotarget. 2015; 6(27):23204-12. PMC: 4695112. DOI: 10.18632/oncotarget.4673. View

3.
Tan L, Ke Z, Tombline G, Macoretta N, Hayes K, Tian X . Naked Mole Rat Cells Have a Stable Epigenome that Resists iPSC Reprogramming. Stem Cell Reports. 2017; 9(5):1721-1734. PMC: 5831052. DOI: 10.1016/j.stemcr.2017.10.001. View

4.
Zhong B, Trobridge G, Zhang X, Watts K, Ramakrishnan A, Wohlfahrt M . Efficient generation of nonhuman primate induced pluripotent stem cells. Stem Cells Dev. 2010; 20(5):795-807. PMC: 3128793. DOI: 10.1089/scd.2010.0343. View

5.
Dewi D, Ishii H, Haraguchi N, Nishikawa S, Kano Y, Fukusumi T . Reprogramming of gastrointestinal cancer cells. Cancer Sci. 2011; 103(3):393-9. PMC: 7713613. DOI: 10.1111/j.1349-7006.2011.02184.x. View